Interim Practical Manual For Designing Setting Up And Assessing Health Facilities In The Context Of Mpox Outbreak

Interim practical manual for designing, setting up, and assessing health facilities in the context of mpox outbreak

This document focuses on the built environment and healthcare facilities, providing guidance on preparing for and responding to mpox outbreaks. It offers technical recommendations for designing, establishing, and managing healthcare facilities to facilitate early identification and treatment of mpox. The guidance includes screening, triage, and temporary isolation facilities; mpox treatment wards within existing healthcare facilities; stand-alone treatment centers; and screening and isolation areas for congregate settings. Organized into two sections, the document covers design principles and implementation strategies, including layouts for temporary facilities using tents.

Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level

Health care-associated infections (HAI) are one of the most common adverse events in care delivery and a major public health problem with an impact on morbidity, mortality and quality of life. At any one time, up to 7% of patients in developed and 10% in developing countries will acquire at least one HAI. These infections also present a significant economic burden at the societal level. However, a large percentage are preventable through effective infection prevention and control (IPC) measures. These new guidelines on the core components of IPC programmes at the national and facility level will enhance the capacity of Member States to develop and implement effective technical and behaviour modifying interventions. They form a key part of WHO strategies to prevent current and future threats from infectious diseases such as Ebola, strengthen health service resilience, help combat antimicrobial resistance (AMR) and improve the overall quality of health care delivery. They are also intended to support countries in the development of their own national protocols for IPC and AMR action plans and to support health care facilities as they develop or strengthen their own approaches to IPC. These are the first international evidence-based guidelines on the core components of IPC programmes. These new WHO guidelines are applicable for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.

Laboratory Biosafety Manual